Montpellier, December 2, 2024 – Launched in 1991, the Awards of the French National Institute of Industrial Property annually honor innovative and promising companies that place industrial property at the core of their development strategy. Quantum Surgical has been awarded the prize in the Start-up category.
Specializing in medical robotics and artificial intelligence, Quantum Surgical develops solutions to treat cancer in a more targeted and less invasive way.
Its flagship innovation, the Epione® robotic platform, has been on the market since 2021. It assists practitioners in performing percutaneous tumor ablations, where one or more needles are inserted through the skin to destroy the tumor. This minimally invasive treatment provides patients with a safe and effective alternative to surgery.
To date, more than 700 patients worldwide have been treated with Epione. Quantum Surgical aims to become a global leader in its field. Since its inception, the company has focused all its efforts on innovation: half of its team is dedicated to research and development, and its technologies are protected through patent filings.
Quantum Surgical pursues its operations expansion in Europe and the United States. Its Epione platform is CE-marked in Europe for abdominal and lung tumors and FDA-approved in the United States for abdominal tumors.
“Our industrial property strategy takes into account the international dimension of our innovations. Indeed, we are continuing our development in Europe and the United States, and at the same time, we are striving to offer our treatment to as many patients as possible. The Epione solution is currently available in about ten hospitals worldwide. We are proud to have brought together teams to create innovative and unique robots that assist both physicians and patients,” explains Bertin Nahum, CEO of Quantum Surgical.
À propos de Quantum Surgical
Quantum Surgical was founded in 2017 by CEO and co-founder Bertin Nahum and a team of pioneering innovators specializing in developing and commercializing advanced medical robotics. Headquartered in Montpellier, France, and Miami, Florida, Quantum Surgical has a growing team of over 120 dedicated professionals.
The Epione platform is designed to revolutionize cancer care by enabling earlier and more precise treatments. Epione is FDA-cleared for CT-guided percutaneous ablation procedures in the abdomen and is compatible with most FDA-approved ablation devices.
Plus d'informations : www.quantumsurgical.com
Press Contact Quantum Surgical
Stéphanie Moy
Tel.: +33 (0)6 32 55 85 48
